{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:22:11Z","timestamp":1793726531760,"version":"4.6.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG084250"],"award-info":[{"award-number":["R01AG084250"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG073323"],"award-info":[{"award-number":["U01AG073323"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG066707"],"award-info":[{"award-number":["R01AG066707"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG076448"],"award-info":[{"award-number":["R01AG076448"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-00870-y","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T19:10:31Z","timestamp":1737486631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Lijun","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxi","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Leverenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-9461","authenticated-orcid":false,"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1736-2847","authenticated-orcid":false,"given":"Feixiong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"870_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin, V. L. et al. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 459\u2013480 (2019).","journal-title":"Lancet Neurol."},{"key":"870_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","volume":"68","author":"AA Moustafa","year":"2016","unstructured":"Moustafa, A. A. et al. Motor symptoms in Parkinson\u2019s disease: A unified framework. Neurosci. Biobehav. Rev. 68, 727\u2013740 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"870_CR3","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/brain\/awaa181","volume":"143","author":"R Cilia","year":"2020","unstructured":"Cilia, R. et al. Natural history of motor symptoms in Parkinson\u2019s disease and the long-duration response to levodopa. Brain 143, 2490\u20132501 (2020).","journal-title":"Brain"},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fneur.2018.00170","volume":"9","author":"H Tibar","year":"2018","unstructured":"Tibar, H. et al. Non-Motor Symptoms of Parkinson\u2019s Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients. Front. Neurol. 9, 170 (2018).","journal-title":"Front. Neurol."},{"key":"870_CR5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA 323, 548\u2013560 (2020).","journal-title":"JAMA"},{"key":"870_CR6","doi-asserted-by":"publisher","first-page":"108085","DOI":"10.1016\/j.neuropharm.2020.108085","volume":"171","author":"W Poewe","year":"2020","unstructured":"Poewe, W., Seppi, K., Marini, K. & Mahlknecht, P. New hopes for disease modification in Parkinson\u2019s Disease. Neuropharmacology 171, 108085 (2020).","journal-title":"Neuropharmacology"},{"key":"870_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"870_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fgene.2020.00424","volume":"11","author":"E Cano-Gamez","year":"2020","unstructured":"Cano-Gamez, E. & Trynka, G. From GWAS to function: using functional genomics to identify the mechanisms underlying complex diseases. Front. Genet 11, 424 (2020).","journal-title":"Front. Genet"},{"key":"870_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","volume":"101","author":"PM Visscher","year":"2017","unstructured":"Visscher, P. M. et al. 10 Years of GWAS Discovery: Biology, Function, and Translation. Am. J. Hum. Genet. 101, 5\u201322 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"gr.272484.27212","DOI":"10.1101\/gr.272484.120","volume":"31","author":"J Xu","year":"2021","unstructured":"Xu, J. et al. Multimodal single-cell\/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer\u2019s disease. Genome Res. 31, gr.272484.272120 (2021).","journal-title":"Genome Res."},{"key":"870_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s43587-021-00138-z","volume":"1","author":"J Fang","year":"2021","unstructured":"Fang, J. et al. Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer\u2019s disease. Nat. Aging 1, 1175\u20131188 (2021).","journal-title":"Nat. Aging"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-018-0223-3","volume":"25","author":"V Swarup","year":"2019","unstructured":"Swarup, V. et al. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. Nat. Med. 25, 152\u2013164 (2019).","journal-title":"Nat. Med."},{"key":"870_CR13","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/med.21709","volume":"40","author":"J Fang","year":"2020","unstructured":"Fang, J. et al. Harnessing endophenotypes and network medicine for Alzheimer\u2019s drug repurposing. Medicinal Res. Rev. 40, 2386\u20132426 (2020).","journal-title":"Medicinal Res. Rev."},{"key":"870_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13195-021-00850-3","volume":"13","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Network medicine links SARS-CoV-2\/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimers Res. Ther. 13, 110 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"870_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10744-6","volume":"10","author":"F Cheng","year":"2019","unstructured":"Cheng, F. et al. A genome-wide positioning systems network algorithm for in silico drug repurposing. Nat. Commun. 10, 3476 (2019).","journal-title":"Nat. Commun."},{"key":"870_CR16","doi-asserted-by":"publisher","first-page":"111717","DOI":"10.1016\/j.celrep.2022.111717","volume":"41","author":"J Xu","year":"2022","unstructured":"Xu, J. et al. Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer\u2019s disease. Cell Rep. 41, 111717 (2022).","journal-title":"Cell Rep."},{"key":"870_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-021-00951-z","volume":"14","author":"J Fang","year":"2022","unstructured":"Fang, J. et al. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer\u2019s disease. Alzheimers Res. Ther. 14, 7 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"870_CR18","doi-asserted-by":"publisher","first-page":"101379","DOI":"10.1016\/j.xcrm.2023.101379","volume":"5","author":"F Cheng","year":"2024","unstructured":"Cheng, F. et al. Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer\u2019s disease. Cell Rep. Med. 5, 101379 (2024).","journal-title":"Cell Rep. Med."},{"key":"870_CR19","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.27659","volume":"34","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat, C. et al. Parkinson\u2019s disease age at onset genome-wide association study: Defining heritability, genetic loci, and \u03b1-synuclein mechanisms. Mov. Disord. 34, 866\u2013875 (2019).","journal-title":"Mov. Disord."},{"key":"870_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-020-00642-8","volume":"7","author":"SK Sieberts","year":"2020","unstructured":"Sieberts, S. K. et al. Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions. Sci. Data 7, 340 (2020).","journal-title":"Sci. Data"},{"key":"870_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41588-023-01300-6","volume":"55","author":"N de Klein","year":"2023","unstructured":"de Klein, N. et al. Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nat. Genet. 55, 377\u2013388 (2023).","journal-title":"Nat. Genet."},{"key":"870_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ajhg.2021.01.012","volume":"108","author":"C Robins","year":"2021","unstructured":"Robins, C. et al. Genetic control of the human brain proteome. Am. J. Hum. Genet. 108, 400\u2013410 (2021).","journal-title":"Am. J. Hum. Genet."},{"key":"870_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo, A. P. et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat. Genet. 53, 143\u2013146 (2021).","journal-title":"Nat. Genet."},{"key":"870_CR24","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/s41588-022-01154-4","volume":"54","author":"T Qi","year":"2022","unstructured":"Qi, T. et al. Genetic control of RNA splicing and its distinct role in complex trait variation. Nat. Genet. 54, 1355\u20131363 (2022).","journal-title":"Nat. Genet."},{"key":"870_CR25","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/nn.4632","volume":"20","author":"B Ng","year":"2017","unstructured":"Ng, B. et al. An xQTL map integrates the genetic architecture of the human brain\u2019s transcriptome and epigenome. Nat. Neurosci. 20, 1418\u20131426 (2017).","journal-title":"Nat. Neurosci."},{"key":"870_CR26","doi-asserted-by":"publisher","first-page":"eabk0637","DOI":"10.1126\/science.abk0637","volume":"377","author":"ME Diaz-Ortiz","year":"2022","unstructured":"Diaz-Ortiz, M. E. et al. GPNMB confers risk for Parkinson\u2019s disease through interaction with \u03b1-synuclein. Science 377, eabk0637 (2022).","journal-title":"Science"},{"key":"870_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/archneur.65.4.460","volume":"65","author":"BF Boeve","year":"2008","unstructured":"Boeve, B. F. & Hutton, M. Refining Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17: Introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch. Neurol. 65, 460\u2013464 (2008).","journal-title":"Arch. Neurol."},{"key":"870_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02404-2","volume":"20","author":"P Guo","year":"2022","unstructured":"Guo, P. et al. Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer\u2019s disease and Parkinson\u2019s disease: a large-scale multi-trait association analysis. BMC Med. 20, 214 (2022).","journal-title":"BMC Med."},{"key":"870_CR29","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/bioinformatics\/btab427","volume":"37","author":"JJ Yang","year":"2021","unstructured":"Yang, J. J. et al. TIGA: target illumination GWAS analytics. Bioinformatics 37, 3865\u20133873 (2021).","journal-title":"Bioinformatics"},{"key":"870_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585 (2013).","journal-title":"Nat. Genet."},{"key":"870_CR31","doi-asserted-by":"publisher","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","volume":"51","author":"E Sollis","year":"2022","unstructured":"Sollis, E. et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 51, D977\u2013D985 (2022).","journal-title":"Nucleic Acids Res."},{"key":"870_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature12043","volume":"496","author":"SA Sarraf","year":"2013","unstructured":"Sarraf, S. A. et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496, 372\u2013376 (2013).","journal-title":"Nature"},{"key":"870_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cels.2017.01.002","volume":"4","author":"CY Chung","year":"2017","unstructured":"Chung, C. Y. et al. In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons. Cell Syst. 4, 242\u2013250.e244 (2017).","journal-title":"Cell Syst."},{"key":"870_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.nbd.2006.04.002","volume":"23","author":"L Lu","year":"2006","unstructured":"Lu, L. et al. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson\u2019s disease: A post-mortem study in human control subjects. Neurobiol. Dis. 23, 409\u2013421 (2006).","journal-title":"Neurobiol. Dis."},{"key":"870_CR35","first-page":"e12350","volume":"8","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. The Alzheimer\u2019s Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer\u2019s disease. Alzheimers Dement. 8, e12350 (2022).","journal-title":"Alzheimers Dement."},{"key":"870_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-020-00229-8","volume":"10","author":"I Kamienieva","year":"2021","unstructured":"Kamienieva, I., Duszy\u0144ski, J. & Szczepanowska, J. Multitasking guardian of mitochondrial quality: Parkin function and Parkinson\u2019s disease. Transl. Neurodegeneration 10, 5 (2021).","journal-title":"Transl. Neurodegeneration"},{"key":"870_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell, A. M., Youle & Richard, J. The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson\u2019s Disease. Neuron 85, 257\u2013273 (2015).","journal-title":"Neuron"},{"key":"870_CR38","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"870_CR39","doi-asserted-by":"publisher","first-page":"105028","DOI":"10.1016\/j.nbd.2020.105028","volume":"144","author":"T-I Kam","year":"2020","unstructured":"Kam, T.-I., Hinkle, J. T., Dawson, T. M. & Dawson, V. L. Microglia and astrocyte dysfunction in parkinson\u2019s disease. Neurobiol. Dis. 144, 105028 (2020).","journal-title":"Neurobiol. Dis."},{"key":"870_CR40","first-page":"188","volume":"18","author":"H Wood","year":"2022","unstructured":"Wood, H. \u03b1-Synuclein-activated microglia are implicated in PD pathogenesis. Nat. Rev. Neurol. 18, 188\u2013188 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"870_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.abb8587","volume":"370","author":"T Bartels","year":"2020","unstructured":"Bartels, T., De Schepper, S. & Hong, S. Microglia modulate neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases. Science 370, 66\u201369 (2020).","journal-title":"Science"},{"key":"870_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41531-021-00221-7","volume":"7","author":"S Yao","year":"2021","unstructured":"Yao, S. et al. A transcriptome-wide association study identifies susceptibility genes for Parkinson\u2019s disease. npj Parkinsons Dis. 7, 79 (2021).","journal-title":"npj Parkinsons Dis."},{"key":"870_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41531-023-00555-4","volume":"9","author":"B Phillips","year":"2023","unstructured":"Phillips, B. et al. Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson\u2019s disease. npj Parkinsons Dis. 9, 107 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"870_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/diseases8020024","volume":"8","author":"N Joshi","year":"2020","unstructured":"Joshi, N., Raveendran, A. & Nagotu, S. Chaperones and Proteostasis: Role in Parkinson\u2019s Disease. Diseases 8, 24 (2020).","journal-title":"Diseases"},{"key":"870_CR45","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3349\/ymj.2022.63.8.724","volume":"63","author":"YJ Kim","year":"2022","unstructured":"Kim, Y. J. et al. The Protein-Protein Interaction Network of Hereditary Parkinsonism Genes Is a Hierarchical Scale-Free Network. Yonsei Med. J. 63, 724\u2013734 (2022).","journal-title":"Yonsei Med. J."},{"key":"870_CR46","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","volume":"23","author":"J Camacho-Pereira","year":"2016","unstructured":"Camacho-Pereira, J. et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metab. 23, 1127\u20131139 (2016).","journal-title":"Cell Metab."},{"key":"870_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich, M. T., Oertel, W. H., Surmeier, D. J. & Geibl, F. F. Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential. Mol. Neurodegeneration 18, 83 (2023).","journal-title":"Mol. Neurodegeneration"},{"key":"870_CR48","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","volume":"30","author":"S Lautrup","year":"2019","unstructured":"Lautrup, S., Sinclair, D. A., Mattson, M. P. & Fang, E. F. NAD+ in Brain Aging and Neurodegenerative Disorders. Cell Metab. 30, 630\u2013655 (2019).","journal-title":"Cell Metab."},{"key":"870_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13195-024-01531-7","volume":"16","author":"A-B Knapskog","year":"2024","unstructured":"Knapskog, A.-B. et al. Sex-specific associations of kynurenic acid with neopterin in Alzheimer\u2019s disease. Alzheimers Res. Ther. 16, 167 (2024).","journal-title":"Alzheimers Res. Ther."},{"key":"870_CR50","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1002\/alz.13162","volume":"19","author":"A-B Knapskog","year":"2023","unstructured":"Knapskog, A.-B. et al. Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer\u2019s disease. Alzheimers Dement. 19, 5573\u20135582 (2023).","journal-title":"Alzheimers Dement."},{"key":"870_CR51","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","volume":"34","author":"B Brakedal","year":"2022","unstructured":"Brakedal, B. et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease. Cell Metab. 34, 396\u2013407.e396 (2022).","journal-title":"Cell Metab."},{"key":"870_CR52","doi-asserted-by":"publisher","first-page":"111208","DOI":"10.1016\/j.mad.2020.111208","volume":"186","author":"BC Gilmour","year":"2020","unstructured":"Gilmour, B. C. et al. Targeting NAD+ in translational research to relieve diseases and conditions of metabolic stress and ageing. Mechanisms Ageing Dev. 186, 111208 (2020).","journal-title":"Mechanisms Ageing Dev."},{"key":"870_CR53","doi-asserted-by":"publisher","first-page":"eabg4574","DOI":"10.1126\/sciadv.abg4574","volume":"7","author":"SJ Ham","year":"2021","unstructured":"Ham, S. J. et al. Loss of UCHL1 rescues the defects related to Parkinson\u2019s disease by suppressing glycolysis. Sci. Adv. 7, eabg4574 (2021).","journal-title":"Sci. Adv."},{"key":"870_CR54","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams, G. P. et al. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain 144, 2047\u20132059 (2021).","journal-title":"Brain"},{"key":"870_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-13-38","volume":"13","author":"M Carbone","year":"2012","unstructured":"Carbone, M., Duty, S. & Rattray, M. Riluzole neuroprotection in a parkinson\u2019s disease model involves suppression of reactive astrocytosis but not GLT-1 regulation. BMC Neurosci. 13, 38 (2012).","journal-title":"BMC Neurosci."},{"key":"870_CR56","doi-asserted-by":"publisher","first-page":"e040527","DOI":"10.1136\/bmjopen-2020-040527","volume":"10","author":"JC Greenland","year":"2020","unstructured":"Greenland, J. C. et al. Azathioprine immunosuppression and disease modification in Parkinson\u2019s disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol. BMJ Open 10, e040527 (2020).","journal-title":"BMJ Open"},{"key":"870_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43053-0","volume":"14","author":"CM Capelle","year":"2023","unstructured":"Capelle, C. M. et al. Early-to-mid stage idiopathic Parkinson\u2019s disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females. Nat. Commun. 14, 7461 (2023).","journal-title":"Nat. Commun."},{"key":"870_CR58","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.neuron.2023.03.021","volume":"111","author":"M Carceles-Cordon","year":"2023","unstructured":"Carceles-Cordon, M., Weintraub, D. & Chen-Plotkin, A. S. Cognitive heterogeneity in Parkinson\u2019s disease: A mechanistic view. Neuron 111, 1531\u20131546 (2023).","journal-title":"Neuron"},{"key":"870_CR59","doi-asserted-by":"publisher","first-page":"896-912","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896-912 (2015).","journal-title":"Lancet"},{"key":"870_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","volume":"15","author":"A Elkouzi","year":"2019","unstructured":"Elkouzi, A., Vedam-Mai, V., Eisinger, R. S. & Okun, M. S. Emerging therapies in Parkinson disease \u2014 repurposed drugs and new approaches. Nat. Rev. Neurol. 15, 204\u2013223 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"870_CR61","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrneurol.2016.196","volume":"13","author":"AJ Espay","year":"2017","unstructured":"Espay, A. J., Brundin, P. & Lang, A. E. Precision medicine for disease modification in Parkinson disease. Nat. Rev. Neurol. 13, 119\u2013126 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"870_CR62","first-page":"1851","volume":"2015","author":"Y Chen","year":"2015","unstructured":"Chen, Y., Cai, X. & Xu, R. Combining Human Disease Genetics and Mouse Model Phenotypes towards Drug Repositioning for Parkinson\u2019s disease. AMIA Annu Symp. Proc. 2015, 1851\u20131860 (2015).","journal-title":"AMIA Annu Symp. Proc."},{"key":"870_CR63","doi-asserted-by":"publisher","first-page":"eabo2467","DOI":"10.1126\/sciadv.abo2467","volume":"9","author":"AJ Lee","year":"2023","unstructured":"Lee, A. J. et al. Characterization of altered molecular mechanisms in Parkinson\u2019s disease through cell type\u2013resolved multiomics analyses. Sci. Adv. 9, eabo2467 (2023).","journal-title":"Sci. Adv."},{"key":"870_CR64","first-page":"545","volume":"7","author":"CB Carroll","year":"2017","unstructured":"Carroll, C. B. & Wyse, R. K. H. Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson\u2019s Disease: Rationale for Clinical. Trial, Curr. Progress. J. Parkinsons Dis. 7, 545\u2013568 (2017).","journal-title":"Trial, Curr. Progress. J. Parkinsons Dis."},{"key":"870_CR65","doi-asserted-by":"publisher","first-page":"e1976","DOI":"10.1212\/WNL.0000000000200182","volume":"98","author":"S Oveisgharan","year":"2022","unstructured":"Oveisgharan, S. et al. Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults. Neurology 98, e1976\u2013e1984 (2022).","journal-title":"Neurology"},{"key":"870_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbr.2016.04.046","volume":"309","author":"Z Sheng","year":"2016","unstructured":"Sheng, Z., Jia, X. & Kang, M. Statin use and risk of Parkinson\u2019s disease: A meta-analysis. Behavioural Brain Res. 309, 29\u201334 (2016).","journal-title":"Behavioural Brain Res."},{"key":"870_CR67","doi-asserted-by":"publisher","first-page":"e14852","DOI":"10.1097\/MD.0000000000014852","volume":"98","author":"J Yan","year":"2019","unstructured":"Yan, J. et al. Effect of statins on Parkinson\u2019s disease: A systematic review and meta-analysis. Medicine 98, e14852 (2019).","journal-title":"Medicine"},{"key":"870_CR68","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamaneurol.2022.3718","volume":"79","author":"KN Stevens","year":"2022","unstructured":"Stevens, K. N. et al. Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 79, 1232\u20131241 (2022).","journal-title":"JAMA Neurol."},{"key":"870_CR69","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/1756285613495723","volume":"7","author":"JJ Chen","year":"2014","unstructured":"Chen, J. J. & Marsh, L. Anxiety in Parkinson\u2019s disease: identification and management. Therapeutic Adv. Neurological Disord. 7, 52\u201359 (2014).","journal-title":"Therapeutic Adv. Neurological Disord."},{"key":"870_CR70","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.29383","volume":"38","author":"MH Flores-Torres","year":"2023","unstructured":"Flores-Torres, M. H. et al. Long-Term Intake of Folate, Vitamin B6, and Vitamin B12 and the Incidence of Parkinson\u2019s Disease in a Sample of U.S. Women and Men. Mov. Disord. 38, 866\u2013879 (2023).","journal-title":"Mov. Disord."},{"key":"870_CR71","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41422-019-0153-8","volume":"29","author":"A Schaffner","year":"2019","unstructured":"Schaffner, A. et al. Vitamin B12 modulates Parkinson\u2019s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection. Cell Res. 29, 313\u2013329 (2019).","journal-title":"Cell Res."},{"key":"870_CR72","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/cns.12557","volume":"22","author":"L Dong","year":"2016","unstructured":"Dong, L. et al. The E3 Ubiquitin Ligase c-Cbl Inhibits Microglia-Mediated CNS Inflammation by Regulating PI3K\/Akt\/NF-\u03baB Pathway. CNS Neurosci. Therapeutics 22, 661\u2013669 (2016).","journal-title":"CNS Neurosci. Therapeutics"},{"key":"870_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14788-x","volume":"11","author":"Y Wei","year":"2020","unstructured":"Wei, Y. et al. Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection. Nat. Commun. 11, 941 (2020).","journal-title":"Nat. Commun."},{"key":"870_CR74","doi-asserted-by":"crossref","unstructured":"Galesic, A. & Pratt, M. R. in Expressed Protein Ligation: Methods and Protocols (ed Miquel Vila-Perell\u00f3) 313\u2013326 (Springer US, 2020).","DOI":"10.1007\/978-1-0716-0434-2_15"},{"key":"870_CR75","doi-asserted-by":"publisher","first-page":"102311","DOI":"10.1016\/j.jchemneu.2023.102311","volume":"132","author":"B Bilal","year":"2023","unstructured":"Bilal, B., Kirazlar, M., Erdogan, M. A., Yigitturk, G. & Erbas, O. Lacosamide exhibits neuroprotective effects in a rat model of Parkinson\u2019s disease. J. Chem. Neuroanat. 132, 102311 (2023).","journal-title":"J. Chem. Neuroanat."},{"key":"870_CR76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","volume":"56","author":"JJ Kim","year":"2023","unstructured":"Kim, J. J. et al. Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease. Nat. Genet. 56, 27\u201336 (2023).","journal-title":"Nat. Genet."},{"key":"870_CR77","doi-asserted-by":"publisher","first-page":"D1143","DOI":"10.1093\/nar\/gkad989","volume":"52","author":"M Schubach","year":"2024","unstructured":"Schubach, M., Maass, T., Nazaretyan, L., R\u00f6ner, S. & Kircher, M. CADD v1.7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions. Nucleic Acids Res. 52, D1143\u2013D1154 (2024).","journal-title":"Nucleic Acids Res."},{"key":"870_CR78","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson, E. et al. Mendelian randomization. Nat. Rev. Methods Prim. 2, 6 (2022).","journal-title":"Nat. Rev. Methods Prim."},{"key":"870_CR79","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41588-019-0385-z","volume":"51","author":"M Wainberg","year":"2019","unstructured":"Wainberg, M. et al. Opportunities and challenges for transcriptome-wide association studies. Nat. Genet. 51, 592\u2013599 (2019).","journal-title":"Nat. Genet."},{"key":"870_CR80","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41588-024-01685-y","volume":"56","author":"M Fujita","year":"2024","unstructured":"Fujita, M. et al. Cell subtype-specific effects of genetic variation in the Alzheimer\u2019s disease brain. Nat. Genet. 56, 605\u2013614 (2024).","journal-title":"Nat. Genet."},{"key":"870_CR81","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41593-022-01128-z","volume":"25","author":"J Bryois","year":"2022","unstructured":"Bryois, J. et al. Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders. Nat. Neurosci. 25, 1104\u20131112 (2022).","journal-title":"Nat. Neurosci."},{"key":"870_CR82","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fphar.2019.00973","volume":"10","author":"MS Ali","year":"2019","unstructured":"Ali, M. S. et al. Propensity score methods in health technology assessment: principles, extended applications, and recent advances. Front. Pharmacol. 10, 973 (2019).","journal-title":"Front. Pharmacol."},{"key":"870_CR83","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"870_CR84","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/bioinformatics\/btw041","volume":"32","author":"Y Cui","year":"2016","unstructured":"Cui, Y. et al. BioCircos.js: an interactive Circos JavaScript library for biological data visualization on web applications. Bioinformatics 32, 1740\u20131742 (2016).","journal-title":"Bioinformatics"},{"key":"870_CR85","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/bioinformatics\/btq419","volume":"26","author":"RJ Pruim","year":"2010","unstructured":"Pruim, R. J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336\u20132337 (2010).","journal-title":"Bioinformatics"},{"key":"870_CR86","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-020-2188-x","volume":"580","author":"K Luck","year":"2020","unstructured":"Luck, K. et al. A reference map of the human binary protein interactome. Nature 580, 402\u2013408 (2020).","journal-title":"Nature"},{"key":"870_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-7-7","volume":"7","author":"D Fazekas","year":"2013","unstructured":"Fazekas, D. et al. SignaLink 2 \u2013 a signaling pathway resource with multi-layered regulatory networks. BMC Syst. Biol. 7, 7 (2013).","journal-title":"BMC Syst. Biol."},{"key":"870_CR88","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/bioinformatics\/btt181","volume":"29","author":"MJ Meyer","year":"2013","unstructured":"Meyer, M. J., Das, J., Wang, X. & Yu, H. INstruct: a database of high-quality 3D structurally resolved protein interactome networks. Bioinformatics 29, 1577\u20131579 (2013).","journal-title":"Bioinformatics"},{"key":"870_CR89","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cell.2015.06.043","volume":"162","author":"EL Huttlin","year":"2015","unstructured":"Huttlin, E. L. et al. The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell 162, 425\u2013440 (2015).","journal-title":"Cell"},{"key":"870_CR90","first-page":"5453","volume":"80","author":"K Xu","year":"2018","unstructured":"Xu, K. et al. Representation learning on graphs with jumping knowledge networks. International Conference on Machine Learning 80, 5453\u20135462 (2018).","journal-title":"International Conference on Machine Learning"},{"key":"870_CR91","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath, T. et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat. Neurosci. 25, 588\u2013595 (2022).","journal-title":"Nat. Neurosci."},{"key":"870_CR92","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors. Cell Syst. 8, 329\u2013337.e324 (2019).","journal-title":"Cell Syst."},{"key":"870_CR93","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"870_CR94","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"},{"key":"870_CR95","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"870_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05116-5","volume":"9","author":"F Cheng","year":"2018","unstructured":"Cheng, F. et al. Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat. Commun. 9, 2691 (2018).","journal-title":"Nat. Commun."},{"key":"870_CR97","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/jamiaopen\/ooaa048","volume":"3","author":"M Ozery-Flato","year":"2020","unstructured":"Ozery-Flato, M., Goldschmidt, Y., Shaham, O., Ravid, S. & Yanover, C. Framework for identifying drug repurposing candidates from observational healthcare data. JAMIA Open 3, 536\u2013544 (2020).","journal-title":"JAMIA Open"},{"key":"870_CR98","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.1038\/s41467-023-43929-1","volume":"14","author":"C Zang","year":"2023","unstructured":"Zang, C. et al. High-throughput target trial emulation for Alzheimer's disease drug repurposing with real-world data. Nat. Commun. 14, 8180 (2023).","journal-title":"Nat. Commun."},{"key":"870_CR99","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2217\/cer-2020-0013","volume":"9","author":"V Allan","year":"2020","unstructured":"Allan, V. et al. Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants. J. Comp. Effectiveness Res. 9, 603\u2013614 (2020).","journal-title":"J. Comp. Effectiveness Res."},{"key":"870_CR100","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin, P. C. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat. Med. 28, 3083\u20133107 (2009).","journal-title":"Stat. Med."},{"key":"870_CR101","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s42256-020-00276-w","volume":"3","author":"R Liu","year":"2021","unstructured":"Liu, R., Wei, L. & Zhang, P. A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data. Nat. Mach. Intell. 3, 68\u201375 (2021).","journal-title":"Nat. Mach. Intell."},{"key":"870_CR102","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","volume":"84","author":"DY Lin","year":"1989","unstructured":"Lin, D. Y. & Wei, L. J. The Robust Inference for the Cox Proportional Hazards Model. J. Am. Stat. Assoc. 84, 1074\u20131078 (1989).","journal-title":"J. Am. Stat. Assoc."},{"key":"870_CR103","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1214\/ss\/1032280214","volume":"11","author":"TJ DiCiccio","year":"1996","unstructured":"DiCiccio, T. J. & Efron, B. Bootstrap confidence intervals. Stat. Sci. 11, 189\u2013228 (1996).","journal-title":"Stat. Sci."},{"key":"870_CR104","doi-asserted-by":"crossref","unstructured":"Kline, A. & Luo, Y. PsmPy: a package for retrospective cohort matching in Python. In 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2022, 1354\u20131357 (2022).","DOI":"10.1109\/EMBC48229.2022.9871333"},{"key":"870_CR105","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.21105\/joss.01317","volume":"4","author":"C Davidson-Pilon","year":"2019","unstructured":"Davidson-Pilon, C. lifelines: survival analysis in Python. J. Open Source Softw. 4, 1317 (2019).","journal-title":"J. Open Source Softw."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00870-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00870-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00870-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T20:03:00Z","timestamp":1737489780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00870-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-00870-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4869009\/v1","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C. has provided consultation to Acadia, Acumen, ALZpath, Aprinoia, Artery, Biogen, Biohaven, BioXcel, Bristol-Myers Squib, Eisai, Fosun, GAP Foundation, Janssen, Karuna, Kinoxis, Lighthouse, Lilly, Lundbeck, LSP\/eqt, Merck, MoCA Cognition, New Amsterdam, Novo Nordisk, Optoceutics, Otsuka, Oxford Brain Diagnostics, Praxis, Prothena, ReMYND, Roche, Scottish Brain Sciences, Signant Health, Simcere, sinaptica, TrueBinding, and Vaxxinity pharmaceutical, assessment, and investment companies. J.C. owns the copyright of the Neuropsychiatric Inventory. J.C. has stocks\/options in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, Acumen. J.B.L. has received consulting fees from consulting fees from Vaxxinity, grant support from GE Healthcare and serves on a Data Safety Monitoring Board for Eisai.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}